In conversation with HUL & DRL

In a CNBC-TV18 exclusive, Satish Reddy of Dr Reddy's Laboratories (DRL) believes that lack of innovation and capital in India unlike China is holding back drug discovery while Sanjeev Mehta of Hindustan Unilever Limited (HUL) says competitors on a level-playing field is good for consumers. Here is a snippet of that exclusive conversation with CNBC-TV18's Shereen Bhan at the Massachusetts Institute of Technology (MIT) in Boston.